|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/138 | |
| A61K 31/343 | |||
| A61K 31/704 | |||
| A61K 33/24 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2753322 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12769146.7 |
| Europos patento paraiškos padavimo data | 2012-09-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-07-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/FR2012/052004 |
| Data | 2012-09-07 |
| (87) | Numeris | WO 2013/034863 |
| Data | 2013-03-14 |
| (30) | Numeris | Data | Šalis |
| 1102727 | 2011-09-08 | FR | |
| 201161573585 P | 2011-09-08 | US |
| (72) |
KLOOS, Ioana, FR
ROBERT, Renata, FR
JACQUET-BESCOND, Anne, FR
DEPIL, Stéphane, FR
CHENEL, Marylore, FR
FOULIARD, Sylvain, FR
BALASUBRAMANIAN, Sriram, US
|
| (73) |
Pharmacyclics, Inc.,
995 East Arques Avenue, Sunnyvale, CA 94085,
US
|
| (54) | SCHEMA D`ADMINISTRATION DU N-HYDROXY-4-{2-[3-(N,N-DIMETHYLAMINOMETHYL)BENZOFURAN-2-YLCARBONYLAMINO]ETHOXY}BENZAMIDE |
| DOSAGE REGIMEN OF N-HYDROXY-4-{2-[3-(N,N-DIMETHYLAMINOMETHYL)BENZOFURAN-2-YLCARBONYLAMINO]ETHOXY}BENZAMIDE |